Peptide record

TPDB09823

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09823
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLISGLLGVGKMLVCGLSGLC
Physicochemical Analysis
C87H156N22O24S3
ARNDEQHFPTWY
GL
1990.51
8.29
1
0
10
+1
-2.93
1.652
157.62
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
6.28
4
Residue Composition
number
0
A
0
R
0
N
0
D
2
C
0
E
0
Q
6
G
0
H
1
I
6
L
1
K
1
M
0
F
0
P
2
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 6 H: 0 I: 1 L: 6 K: 1 M: 1 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
21
C87H156N22O24S3
1990.51
8.29
+1
-2.93
1.652
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
10.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
20.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

IC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
10.2 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

led P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
10.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
20.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

IC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
10.2 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

led P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
10.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
20.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
10.2 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
10.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
20.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 10.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
10.2 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 20.4 ug/ml), Gram+ bacteria S. aureus (MIC 20.4 ug/ml), and yeast C. albicans (MIC 10.2 ug/ml). Updated 7/2021